JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M103409200 on June 1, 2001

J. Biol. Chem., Vol. 276, Issue 31, 28991-28998, August 3, 2001
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/31/28991    most recent
M103409200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Puri, N.
Right arrow Articles by Seidman, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Puri, N.
Right arrow Articles by Seidman, M. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Targeted Gene Knockout by 2'-O-Aminoethyl Modified Triplex Forming Oligonucleotides*

Nitin PuriDagger , Alokes MajumdarDagger , Bernard Cuenoud§, Francois Natt, Pierre Martin, Andre BoydDagger , Paul S. Miller||, and Michael M. SeidmanDagger **

From the Dagger  NIA, National Institutes of Health, Baltimore, Maryland 21224, the § Novartis Horsham Research Centre, Horsham, West Sussex, RH12 4AB United Kingdom,  Novartis Pharma, Ltd., 4002 Basel, Switzerland, and the || Department of Biochemistry and Molecular Biology, School of Hygiene and Public Health, Johns Hopkins University, Baltimore, Maryland 21205

Triplex forming oligonucleotides (TFOs) are of interest because of their potential for facile gene targeting. However, the failure of TFOs to bind target sequences at physiological pH and Mg2+ concentration has limited their biological applications. Recently, pyrimidine TFOs with 2'-O-aminoethyl (AE) substitutions were shown to have enhanced kinetics and stability of triplex formation (Cuenoud, B., Casset, F., Husken, D., Natt, F., Wolf, R. M., Altmann, K. H., Martin, P., and Moser H. E. (1998) Angew. Chem. Int. Ed. 37, 1288-1291). We have prepared psoralen-linked TFOs with varying amounts of the AE-modified residues, and have characterized them in biochemical assays in vitro, and in stability and HPRT gene knockout assays in vivo. The AE TFOs showed higher affinity for the target in vitro than a TFO with uniform 2'-OMe substitution, with relatively little loss of affinity when the assay was performed in reduced Mg2+. Once formed they were also more stable in "physiological" buffer, with the greatest affinity and stability displayed by the TFO with all but one residue in the AE format. However, TFOs with lesser amounts of the AE modification formed the most stable triplexes in vivo, and showed the highest HPRT gene knockout activity. We conclude that the AE modification can enhance the biological activity of pyrimidine TFOs, but that extensive substitution is deleterious.


* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

** To whom correspondence should be addressed: LMG/NIA National Institutes of Health, 5600 Nathan Shock Dr., Baltimore, MD 21224. Tel.: 410-558-8565; Fax: 410-558-8157; E-mail: seidmanm@grc.nia.nih.gov.


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Ann. N. Y. Acad. Sci.Home page
J. M. KALISH and P. M. GLAZER
Targeted Genome Modification via Triple Helix Formation
Ann. N.Y. Acad. Sci., November 1, 2005; 1058(1): 151 - 161.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
S. Richards, S.-T. Liu, A. Majumdar, J.-L. Liu, R. S. Nairn, M. Bernier, V. Maher, and M. M. Seidman
Triplex targeted genomic crosslinks enter separable deletion and base substitution pathways
Nucleic Acids Res., September 25, 2005; 33(17): 5382 - 5393.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
A. MAJUMDAR, N. PURI, N. McCOLLUM, S. RICHARDS, B. CUENOUD, P. MILLER, and M. M. SEIDMAN
Gene Targeting by Triple Helix-Forming Oligonucleotides
Ann. N.Y. Acad. Sci., December 1, 2003; 1002(1): 141 - 153.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
R. A. Cassidy, N. Puri, and P. S. Miller
Effect of DNA target sequence on triplex formation by oligo-2'-deoxy- and 2'-O-methylribonucleotides
Nucleic Acids Res., July 15, 2003; 31(14): 4099 - 4108.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Majumdar, N. Puri, B. Cuenoud, F. Natt, P. Martin, A. Khorlin, N. Dyatkina, A. J. George, P. S. Miller, and M. M. Seidman
Cell Cycle Modulation of Gene Targeting by a Triple Helix-forming Oligonucleotide
J. Biol. Chem., March 21, 2003; 278(13): 11072 - 11077.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
F. Nagatsugi, S. Sasaki, P. S. Miller, and M. M. Seidman
Site-specific mutagenesis by triple helix-forming oligonucleotides containing a reactive nucleoside analog
Nucleic Acids Res., March 15, 2003; 31(6): e31 - e31.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
M. P. Knauert and P. M. Glazer
Triplex forming oligonucleotides: sequence-specific tools for gene targeting
Hum. Mol. Genet., October 1, 2001; 10(20): 2243 - 2251.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.